Truett-Hurst (OTCMKTS:THST – Get Free Report) and Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) are both consumer staples companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, valuation and profitability.
Analyst Ratings
This is a summary of recent ratings and target prices for Truett-Hurst and Arcadia Biosciences, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Truett-Hurst | 0 | 0 | 0 | 0 | 0.00 |
| Arcadia Biosciences | 1 | 0 | 0 | 0 | 1.00 |
Valuation and Earnings
This table compares Truett-Hurst and Arcadia Biosciences”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Truett-Hurst | $6.74 million | N/A | -$850,000.00 | N/A | N/A |
| Arcadia Biosciences | $4.86 million | 0.22 | -$2.34 million | ($4.56) | -0.10 |
Truett-Hurst has higher revenue and earnings than Arcadia Biosciences.
Profitability
This table compares Truett-Hurst and Arcadia Biosciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Truett-Hurst | N/A | N/A | N/A |
| Arcadia Biosciences | -234.53% | -183.50% | -91.25% |
Institutional & Insider Ownership
17.7% of Arcadia Biosciences shares are owned by institutional investors. 17.1% of Truett-Hurst shares are owned by insiders. Comparatively, 4.5% of Arcadia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Risk and Volatility
Truett-Hurst has a beta of 0.29, meaning that its share price is 71% less volatile than the S&P 500. Comparatively, Arcadia Biosciences has a beta of 0.53, meaning that its share price is 47% less volatile than the S&P 500.
Summary
Truett-Hurst beats Arcadia Biosciences on 6 of the 9 factors compared between the two stocks.
About Truett-Hurst
Truett-Hurst, Inc., together with its subsidiary, H.D.D. LLC, produces, markets, and sells wines primarily in the United States. It produces wine from a range of varietals, including the Pinot Noir, Chardonnay, Sauvignon Blanc, Zinfandel, Petite Sirah, Syrah, and other red blends. The company offers its products primarily under the VML, Truett Hurst, and Svengali brands directly through its tasting rooms, wine clubs, and winery Websites. Truett-Hurst, Inc. was founded in 2007 and is headquartered in Healdsburg, California.
About Arcadia Biosciences
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Receive News & Ratings for Truett-Hurst Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Truett-Hurst and related companies with MarketBeat.com's FREE daily email newsletter.
